Correlation Between KABE Group and Sprint Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both KABE Group and Sprint Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KABE Group and Sprint Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KABE Group AB and Sprint Bioscience AB, you can compare the effects of market volatilities on KABE Group and Sprint Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KABE Group with a short position of Sprint Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of KABE Group and Sprint Bioscience.

Diversification Opportunities for KABE Group and Sprint Bioscience

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between KABE and Sprint is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding KABE Group AB and Sprint Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sprint Bioscience and KABE Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KABE Group AB are associated (or correlated) with Sprint Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sprint Bioscience has no effect on the direction of KABE Group i.e., KABE Group and Sprint Bioscience go up and down completely randomly.

Pair Corralation between KABE Group and Sprint Bioscience

Assuming the 90 days trading horizon KABE Group AB is expected to generate 0.35 times more return on investment than Sprint Bioscience. However, KABE Group AB is 2.86 times less risky than Sprint Bioscience. It trades about -0.13 of its potential returns per unit of risk. Sprint Bioscience AB is currently generating about -0.07 per unit of risk. If you would invest  31,599  in KABE Group AB on August 29, 2024 and sell it today you would lose (2,199) from holding KABE Group AB or give up 6.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

KABE Group AB  vs.  Sprint Bioscience AB

 Performance 
       Timeline  
KABE Group AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days KABE Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Sprint Bioscience 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sprint Bioscience AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Sprint Bioscience sustained solid returns over the last few months and may actually be approaching a breakup point.

KABE Group and Sprint Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with KABE Group and Sprint Bioscience

The main advantage of trading using opposite KABE Group and Sprint Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KABE Group position performs unexpectedly, Sprint Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sprint Bioscience will offset losses from the drop in Sprint Bioscience's long position.
The idea behind KABE Group AB and Sprint Bioscience AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stocks Directory
Find actively traded stocks across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences